Raffles Medical Group Ltd (SGX: BSL) is one of the largest private healthcare groups in Singapore. Started in 1976, it now operates in various cities including Singapore, China, Japan, Vietnam, and Cambodia. This morning, the healthcare company announced its financial results for the second quarter ended 30 June 2018. Financial highlights Revenue for the latest quarter rose 0.1% year-on-year to S$120.2 million. Revenue from the Healthcare Services division grew 5.4%, while revenue from the Hospital Services division fell by 2.3%. The higher revenue from the Healthcare Services division was due to the addition of new corporate clients and a new contract to offer Air Borders screening services, which was awarded by the Ministry of Health and Civil Aviation Authority of Singapore. On the oth

My view: S'pore-Aipha-picks: MY PICK: 1. Raffles Medical (RFMD SP) Px/Tgt SGD1.11/1.20 2. Venture Mfg (VMS SP) Px/Tgt SGD17.50/18.50 3. UOB (UOB SP) Px/Tgt SGD27.00/31.80 4. OCBC (OCBC SP) Px/Tgt SGD11.57/13.52 5. DBS (DBS SP) Px/Tgt SGD26.75/28.95 6. SingTel (ST SP) Px/Tgt SGD3.21/4.22 7. SingPost (SPOST SP) Px/Tgt SGD1.34/1.59 8. CD (CD SP) Px/Tgt SGD2.30/2.43 9. SembCorp Ind (SCI SP) Px/Tgt SGD2.68/3.60 10. City Dev (CIT SP) Px/Tgt SGD9.90/11.50 11. Capitaland (CAPL SP) Px/Tgt SGD3.15/4.10 Click HERE to contact us for the full version of this UOB Kay Hian stock research report.Thanks & RegardsInvest Stock - www.facebook.com/investstockAny expression of trading idea found on this website is for sharing only and does not constitute an invitation to trade or investment advice. Please r

Numerous companies are about to release their earnings report card. There are two companies in particular that I will be keeping a close eye on. They are Raffles Medical Group Ltd (SGX:BSL) and AEM Holdings Ltd (SGX: AWX). Both these companies have been hit by massive sell-downs, leading to share prices falling more than 30% from their peaks. Raffles Medical has been hit by negative market sentiment due to a saturated private healthcare market in Singapore and regional competition for medical tourism. AEM Holdings, on the other hand, after surging in 2017, has fallen hard from its peak due to fears that a US-China trade war can impact the company’s earnings. However, both companies, in my view, have a bright future and the sell down might be overdone. Here’s what I’m looking out for

Temasek Holdings recently reported a net portfolio value of $308 billion, up by 12% from $275 billion in 2017. As the country’s institutional investor, Temasek knows that it has no room for failure. After all, the funds generated by Temasek’s investments are used to supplement Singapore government’s budget spending and for growing our national reserves. Thus, identifying global trends is critical in guiding investments towards a better, smarter and more connected world in the long term. At the recent annual Temasek Review 2018, Temasek shared the 6 key global trends that has guided and will continue to guide its investments. Looking at Temasek’s newly invested companies, you will see that a common theme is that they are innovative, and have the potential to cre

MARKET OVERVIEW- The market looked set for a weaker open as tech stocks led US stocks lower and oil skidded more than 4% on resumption of Libyan production and talk of possible supply increases by Saudi Arabia and Russia.- Technically, underlying support for STI lies at at 3,190-3,200 with immediate resistance seen at 3,300.CORPORATE RESULTS*Keppel REIT- 2Q18 DPU remained flat at 1.42¢ on marginally higher distributable income offset by increased number of units.- Gross revenue and NPI grew to $51.7m (+29.6%) and $43.2m (+35.5%) respectively, mainly due to increase in one-off income, and higher contribution from Bugis Junction Towers and Ocean Financial Centre partially offset by weaker contribution from 275 George Street. - Average signing rent for Singapore office leases was approx. $10

Raffles Medical Group Ltd (SGX: BSL) runs hospital and healthcare services in Singapore. It also has a network of clinics in five countries and thirteen cities. In addition, the company is developing two hospitals in China. For investors who would like to learn more about the company, we can start with a simple premise – how does it make its cash. The table below comes from Raffles Medical’s annual report. Source: Raffles Medical 2017 Annual Report From the above, we can see that Raffles Medical categorized its income sources into three groups. Hospital Services This segment accounts for the biggest share of the company’s revenue and profit before tax. The Raffles Hospital in Bugis falls under this category where it provides specialised medical services and operates medica

Growth investors are investors who aim to invest in companies that are able to grow their businesses at high rates in the future. In this article, I would like to point out three reasons why growth investors might find Raffles Medical Group Ltd (SGX: BSL) an interesting candidate for further research. Historical growth rates Growth investors tend to be interested in companies that possess a good historical track record of growth, and the potential to continue posting a high growth rate in the future. In the case of Raffles Medical, it has demonstrated a positive growth track record. First of all, revenue has grown from S$312 million in 2012 to S$478 million in 2017, up by a compounded annual growth rate (CAGR) of 8.9% during the period. Next, operating profit has grown from S$66 million

Raffles Medical Group Ltd (SGX: BSL) runs hospital and healthcare services in Singapore. It also has a network of clinics in five countries and thirteen cities. In addition, the company is developing two hospitals in China. One of the things that I like to do when analysing a company is to study its track record. The past is no guarantee of the future. But historical information is the most reliable thing that we can use as our basis to forecast what lies ahead. And this brings me to the main purpose of this article, which is to have a quick overview of Raffles Medical’s historical business growth. The table below is a snapshot of the company’s important financial metrics from FY2013 (financial year ended 31 December 2013) to FY2017 (financial year ended 31 December 2017): Source: Raff

I’m a value investor. So, I like to search for companies that are trading at good value. A list of stocks that are near their respective 52-week lows is a good place to start my search for a good reason. These are the stocks that are either neglected or beaten down by investors. And, some of these stocks can be bargains in relation to their actual economic worth because market participants can at times react too negatively to certain companies that have sound long-term prospects but that have experienced some short-term stumbles. As such, I will screen for stocks that are trading near 52-week lows nearly once every week. There are many stocks that pop up on my screen each time I run it. So, what are the companies that have shown up on this week’s list? Here are three of them: Jardine

Raffles Medical Group Ltd (SGX: BSL) is a private healthcare services provider with operations in Singapore and a number of other Asian countries. In Singapore, the company has its flagship Raffles Hospital. It is also developing two hospitals in the Chinese cities of Chongqing and Shanghai. At the current price of S$1.02 (at the time of writing), Raffles Medical’s shares are just 1 cent higher than the 52-week low price of S$1.01. This raises a question: Is Raffles Medical cheap now? This question is important because if the firm’s shares are cheap, it might be a good opportunity for investors. Unfortunately, there is no easy answer. However, we can still get some insight by comparing Raffles Medical’s current valuations with the market’s valuation. The three valuation metrics

In a recent article, I discussed the need to think in terms of decades and even generations when it comes to investing in the stock market. In the article, I mentioned: “It requires a considerable amount of time for any business to do well. By focusing on the long-term, we are forced to think about the quality and fundamentals of the company we are investing in. If we have an “investing” time frame of just one month, we would only be looking at stock price fluctuations alone, and this will be to the detriment of our portfolio. The daily fluctuation in stock prices will not do any good for our psychological health as well. However, if our investing time frame is measured in decades or even generations, we will be forced to think about the things that matter: The long-term prospects o

Here are some of the most interesting articles that have appeared on the Motley Fool Singapore’s website this week. How To Identify REITs That Have A Portfolio That Can Appreciate In Value A real estate investment trust (REIT) can grow its portfolio either through acquisitions or appreciation of its property value. The former usually requires the REIT to take on more risk through additional borrowings, while the latter is due to the nature of the properties held by the REIT. In his article here, Motley Fool Singapore contributor, Jeremy Chia, shows us some ways to identify REITs with a portfolio that can grow in value. REITs discussed include Parkway Life REIT (SGX: C2PU) and CapitaLand Retail China Trust (SGX: AU8U). Raffles Medical Group Ltd’s Stock Price At A Multi-Year Low: Is It T

iFAST Corporation Ltd (SGX: AIY) and Raffles Medical Group Ltd (SGX: BSL) have seen their share prices fall hard from their respective peaks. But, I believe that these two companies could go on to trounce the market in the years to come. Here’s why. Company 1: iFAST iFAST is an Internet-based investment products distribution platform that provides a comprehensive range of investment products and services to both corporate clients and retail investors. At the time of writing, iFAST’s shares are exchanging hands at S$1.06 apiece, which is down 32% from a peak of S$1.565 seen in May 2015. Mrs. Market may have been spooked by the losses the company is currently making in its China business. In 2017, iFAST’s China operations posted a loss, just like in 2016. However, the company’s busin

Raffles Medical Group Ltd (SGX: BSL), a one-time stock market darling, has been facing numerous challenges in recent years. A saturated private healthcare market in Singapore and strong competition from regional players for medical tourists have led to stagnating growth for the company. Consequently, market participants have driven its stock price down by nearly 40% from its all-time high that was reached in July 2015. Analysts from DBS Group Holdings Ltd’s (SGX: D05) research arm have even downgraded Raffles Medical Group and have set a near-term target price of S$1.00, which is just below its current stock price of S$1.01. Investors who are holding on to Raffles Medical’s shares are likely feeling the pressure to sell. However, as a shareholder of Raffles Medical, I believe the compa

I revealed earlier in the year that I have a few hundred drafts in my blogging account, these are blogs which I started and did not finish. It is terrible, I know. There were always so many things going on in my mind and I am sure they... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]

I’m a value investor. So, I like to search for companies that are trading at good value. A list of stocks that are near their respective 52-week lows is a good place to start my search for a good reason. These are the stocks that are either neglected or beaten down by investors. And, some of these stocks can be bargains in relation to their actual economic worth because market participants can at times react too negatively to certain companies that have sound long-term prospects but have experienced some short-term stumbles. As such, I will screen for stocks that are trading near 52-week lows nearly once every week. There are many stocks that pop up on my screen each time I run it. In here, let’s look at three such stocks: Raffles Medical Group Ltd (SGX: BSL), Thai Beverage Public Co

It is that time in the year where everyone starts to travel for the June holidays and for summer vacations. Depending on where you’ll be visiting, doctors may recommend that you get vaccinated against certain diseases endemic in specific parts of the world. As Singaporeans, we always want things to get cheaper, better and faster. There are many vaccination options that travellers can opt for, whether it is heading to polyclinics, public hospitals or private clinics. In general, public healthcare providers are usually more affordable than private ones, but there may be exceptions and the difference may not be as significant as you think. Here is your guide on the various options available, so you can make the most informed decision before travelling abroad and enjoying peace of

We are reaching the tail-end of the earnings season. Given that many companies have already reported their results, it might be useful to categorise them into three buckets of positive, negative and mixed. In this article, I will look at two companies that have recently reported positive results. Venture Corporation Ltd (SGX: V03) is the first company that we will look at in this article. As a quick introduction, Venture Corporation is an electronics manufacturing services provider with expertise in a wide range of activities. Overall, quarterly revenue was up by 1.5% year-on-year to S$856.0 million. Profit attributable to shareholders was up by 72.2% year-on-year to S$83.7 million. As a result, Venture’s diluted earnings per share (EPS) was up by 67.4% year-on-year to 28.8 cents. As at

Healthcare remains on the top of mind this week, as Parliament debated the President’s address. Some of the ideas discussed during the debates include exempting primary healthcare services from GST, and making Medisave usage more flexible. Outside of Parliament, there were calls to do more to attract fresh tech talent into healthcare. The Ministry of Health projects that 30,000 additional healthcare workers will be needed by 2020. Read Also: Singapore’s Healthcare Outcomes Are Among The Best In The World. Why Is The Government Still Planning To Spend More? While facing growing challenges to meet rising expectations of patients alongside pressure to keep solutions affordable, the promise of new technology and growing demand means the future of the healthcare sector remains bright. To

Raffles Medical Group Ltd (SGX: BSL) is one of the largest private healthcare groups in Singapore. Established in 1976, it now operates in a total of 12 cities across Singapore, China, Japan, Vietnam and Cambodia. Of late, the company’s stock has not been doing well. From an all-time high of S$1.675 seen in May 2016, Raffles Medical’s shares closed at S$1.08 each on 18 May 2018, down by 36%. One of the main possible reasons for this poor performance is that Raffles Medical’s business growth has slowed to a crawl. From 2014 to 2017, the company’s earnings per share has stayed at around 4.0 Singapore cents throughout. However, instead of looking at just the earnings per share alone, there’s another angle to analyse a company, and that would be to look at its re